Aprocitentan (a dual endothelin receptor antagonist) for Treatment-Resistant Hypertension. McCoy EK, Lisenby KM. J Cardiovasc Pharmacol 2021 Apr 5. pii: 00005344-900000000-98239.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

McCoy EK, Lisenby KM. Aprocitentan (a dual endothelin receptor antagonist) for Treatment-Resistant Hypertension. J Cardiovasc Pharmacol 2021 Apr 5. pii: 00005344-900000000-98239.
PMID: 34001723